AnnJi
TWO: 7754.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wenying Huang
- Headquarters
- Taipei, Taiwan
- IPO year
- 2024
- Market cap
- NT$6.1B
- Website
- https://www.ajpharm.com
Loading 7754…
Loading profile data…Frequently asked questions about 7754
What does AnnJi (7754.TWO) do?
AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders. It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy, a neurodegenerative disease; AJ202 for androgenetic alopecia; AJ302, a histone deacetylase 6 inhibitor for the prevention an...
Where does 7754.TWO trade?
AnnJi (7754.TWO) trades on the Taipei Exchange.
What sector is 7754.TWO in?
AnnJi (7754.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AnnJi?
Wenying Huang is the chief executive officer of AnnJi (7754.TWO).
Where is AnnJi headquartered?
AnnJi is headquartered in Taiwan.
Does 7754.TWO pay a dividend?
AnnJi (7754.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 7754.TWO go public?
AnnJi (7754.TWO) completed its initial public offering in 2024.